Company intelligence / Profile preview

Shanghai Marya Pharmaceutical Engineering & Project Co., Ltd.

Shanghai, Shanghai, Chinamarya.com.cn ↗
Ownership
Private
Employees
~50
Development stage
Phase 3
01

Overview

Not applicable (manufacturing and engineering company, not a drug development company)

Industry
Contract Manufacturing Organization
02

Drug pipeline

3 assets

TNG

Phase 3
Indications
HIV/AIDS

2 more assets in the full pipeline.

Request access →
03

Partnerships

NovartisUS pharmaMSDNBA (Zimbabwe National Biotechnology Administration)Novo NordiskTechno drugs

Beyond the preview

Go deeper on Shanghai Marya Pharmaceutical Engineering & Project Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Marya Pharmaceutical Engineering & Project Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call